Abstract
Background Refractoriness to platelet transfusion is an understudied phenomenon in critically ill patients. Our objective was to evaluate the prevalence, risk factors, and clinical outcomes of platelet refractoriness among patients in a tertiary-care intensive care unit (ICU). Methods A retrospective cohort study included all patients (age >14 years) who were admitted to a tertiary-care medical-surgical ICU between 2011 and 2016 and received ≥2 platelet transfusions during their ICU stay. We calculated platelet increment (PI) and corrected count increment (CCI). Results A total of 267 patients were enrolled in the study, collectively receiving 1357 transfusions with a median of 4.0 (interquartile range: 2.0, 6.0) transfusions per patient. The median pretransfusion platelet count was 31000.0 × 106/L (interquartile range: 16000.0, 50000.0). The median PI was 6000 × 106/L. The prevalence of platelet transfusion refractoriness was 54.8% based on PI < 10000 × 106/L and 57.0% based on CCI <5000. Patients admitted under hepatology/liver transplant had the highest rates of platelet refractoriness (69.6%), while those under general surgery had the lowest rate (43.2%). Younger age, nontrauma admission, and larger spleen size were associated with platelet refractoriness. Finally, refractoriness was associated with increased length of stay in the ICU (p = 0.02), but not with mortality. Conclusions Platelet transfusion refractoriness was highly (>50%) prevalent in ICU patients. However, it was not associated with increased mortality.
Highlights
Refractoriness to platelet transfusion is an understudied phenomenon in critically ill patients
A total of 267 patients were enrolled in the study, collectively receiving 1357 transfusions with a median of 4.0 transfusions per patient. e median pretransfusion platelet count was 31000.0 × 106/L. e median platelet increment (PI) was 6000 × 106/L. e prevalence of platelet transfusion refractoriness was 54.8% based on PI < 10000 × 106/L and 57.0% based on corrected count increment (CCI)
Patients and Setting. is was a retrospective cohort study that was conducted in the adult noncardiac intensive care unit (ICU) of King Abdulaziz Medical City, Riyadh, Saudi Arabia. e Institutional Review Board of the Ministry of National Guard Health Affairs approved this study. e hospital was a tertiary-care center in Riyadh, with a capacity of >1000 beds treating a variety of medical conditions and specialties including hematology, oncology, and hematopoietic stem cell transplantation. e ICUs collectively had 60 beds servicing medical, surgical, and trauma patients
Summary
Refractoriness to platelet transfusion is an understudied phenomenon in critically ill patients. Our objective was to evaluate the prevalence, risk factors, and clinical outcomes of platelet refractoriness among patients in a tertiary-care intensive care unit (ICU). A retrospective cohort study included all patients (age >14 years) who were admitted to a tertiary-care medical-surgical ICU between 2011 and 2016 and received ≥2 platelet transfusions during their ICU stay. E median pretransfusion platelet count was 31000.0 × 106/L (interquartile range: 16000.0, 50000.0). E median PI was 6000 × 106/L. e prevalence of platelet transfusion refractoriness was 54.8% based on PI < 10000 × 106/L and 57.0% based on CCI 50%) prevalent in ICU patients. It was not associated with increased mortality
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
